Found: 17
Select item for more details and to access through your institution.
Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2021, v. 128, p. 18, doi. 10.1111/bju.15364
- By:
- Publication type:
- Article
Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1295865
- By:
- Publication type:
- Article
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 1, p. 25, doi. 10.1007/s40290-023-00508-5
- By:
- Publication type:
- Article
POST-TRAUMATIC INTERCOSTAL LIVER HERNIATION.
- Published in:
- ANZ Journal of Surgery, 2008, v. 78, n. 7, p. 615, doi. 10.1111/j.1445-2197.2008.04586.x
- By:
- Publication type:
- Article
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231177018
- By:
- Publication type:
- Article
Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
- Published in:
- Current Oncology, 2023, v. 30, n. 1, p. 923, doi. 10.3390/curroncol30010070
- By:
- Publication type:
- Article
New survival standards for advanced melanoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Current management of renal cell cancer.
- Published in:
- Trends in Urology & Men's Health, 2017, v. 8, n. 2, p. 21, doi. 10.1002/tre.571
- By:
- Publication type:
- Article
Recent developments in melanoma management.
- Published in:
- Trends in Urology & Men's Health, 2016, v. 7, n. 4, p. 8, doi. 10.1002/tre.529
- By:
- Publication type:
- Article
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 642, doi. 10.1111/ajco.13732
- By:
- Publication type:
- Article
Treatment outcomes for patients with metastatic castrate‐resistant prostate cancer following docetaxel for hormone‐sensitive disease.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 1, p. 36, doi. 10.1111/ajco.13447
- By:
- Publication type:
- Article
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 5, p. e97, doi. 10.1111/ajco.13109
- By:
- Publication type:
- Article
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 113, doi. 10.1007/s00262-016-1926-2
- By:
- Publication type:
- Article
Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors 'A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome'.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.765608
- By:
- Publication type:
- Article
Hypertensive crisis precipitated by insulin-induced hypoglycemia with end-stage renal failure.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer.
- Published in:
- BJUI Compass, 2022, v. 3, n. 3, p. 205, doi. 10.1002/bco2.129
- By:
- Publication type:
- Article